Opportunities for Organ Donor Intervention Research

The National Academic Press, October 10, 2017
by By I. Glenn Cohen (Faculty Director) and members of the Committee on Issues in Organ Donor Intervention Research

The organ donation and transplantation system strives to honor the gift of donated organs by fully using those organs to save and improve the quality of the lives of their recipients. While most related… Read More

Pre-order now and get 30% off! Specimen Science

MIT Press, September 2017
by Edited by Holly Fernandez Lynch (Executive Director), Barbara E. Bierer, I. Glenn Cohen (Faculty Director), and Suzanne M. Rivera

Pre-order through MIT Press and receive 30% off using discount code MSPECIMEN30: Order now! This edited volume stems from a conference in 2015 that brought together leading experts to address key… Read More

ORDER NOW & GET 20% OFF! Law, Religion, and Health in the United States

Cambridge University Press, July 2017
by Holly Fernandez Lynch (Executive Director), I. Glenn Cohen (Faculty Director), and Elizabeth Sepper

About the Book: While the law can create conflict between religion and health, it can also facilitate religious accommodation and protection of conscience. Finding this balance is critical to addressing… Read More

2017-2018 Petrie-Flom Center Student Fellowship
Harvard Law School

Deadline: August 11, 2017

The deadline for applications for the 2017-2018 fellowship is now closed.  The Center and Student Fellowship. The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics is an interdisciplinary… Read More

State AGs Ask For Emergency Court Order To Keep Trump From Cutting Off Insurer Subsidies

Kaiser Health News, October 19, 2017

KHN Morning Briefing: Summaries of health policy coverage from major news organizations "It's long past time President Donald Trump learn that he doesn't get to pick and choose which laws… Read More

Cutting Off Insurer Payments Increases Number Of People Who Get Help Through Other Subsidies

Kaiser Health News, October 19, 2017

KHN Morning Briefing: Summaries of health policy coverage from major news organizations Stopping insurer subsidies is like pushing down on one end of a see-saw only to see the other end go up because… Read More

Despite GOP Efforts To Corral Medicaid Spending, States Expand Benefits

Kaiser Health News, October 19, 2017
by Phil Galewitz

While congressional Republicans and President Donald Trump have been seeking major cuts in federal funding of Medicaid, 26 states this year expanded or enhanced benefits and at least 17 plan to do so next… Read More

Justice Department reveals charges against Chinese fentanyl distributors

Washington Post, October 17, 2017
by Matt Zapotosky and Sari Horwitz

U.S. prosecutors have charged two Chinese nationals who sold fentanyl to American customers over the Internet in a massive international conspiracy case, the Justice Department announced Tuesday. The case… Read More

Stunner On Birth Control

Kaiser Health News, October 16, 2017
by Julie Rovner

Few people were surprised last week when the Trump administration issued a rule to make it easier for some religious employers to opt out of offering no-cost prescription birth control to their female… Read More

It’s Not Likely Court Will Order Administration To Pay Subsidies

Kaiser Health News, October 16, 2017

KHN Morning Briefing: Summaries of health policy coverage from major news organizations Nearly 20 states have sued over President Donald Trump's decision to stop the insurer subsidies. But, “Forcing… Read More

Trump’s Move To End Insurer Subsidies May Force Congress To Act After Months Of Stagnation

Kaiser Health News, October 16, 2017

KHN Morning Briefing: Summaries of health policy coverage from major news organizations Uncertainty over the payments to insurers has loomed over Congress for months, and senators have been trying… Read More

NHS patients to be asked about sexuality

BBC News, October 15, 2017

Health professionals in England are to be told to ask patients aged 16 or over about their sexual orientation, under new NHS guidelines. NHS England said no-one would be forced to answer the question but… Read More

The Drug Industry’s Triumph over the DEA

Washington Post, October 15, 2017
by Scott Higham and Lenny Bernstein

In April 2016, at the height of the deadliest drug epidemic in U.S. history, Congress effectively stripped the Drug Enforcement Administration of its most potent weapon against large drug companies suspected… Read More

Bernard J. Beazley Chair in Health Law and Policy
Loyola University Chicago School of Law

Deadline: Open until filled

Loyola University Chicago School of Law, a leading urban Jesuit Catholic law school, is currently seeking candidates to fill its chair in health law and policy, named in honor of law school alumnus and… Read More

Trump’s Order Advances GOP Go-To Ideas To Broaden Insurance Choices, Curb Costs

Kaiser Health News, October 12, 2017
by Julie Appleby

The Trump administration Thursday advanced a wide-ranging executive order aimed at expanding lower-cost insurance options, allowing employers to give workers money to buy their own coverage and slowing… Read More

Innovative Contracting for Pharmaceuticals and Medicaid’s Best-Price Rule

Journal of Health Politics, Policy and Law, September 28, 2017
by Rachel E. Sachs (Academic Fellow Alumna), Nicholas Bagley, and Darius N. Lakdawalla

From the paper: In recent years, drug manufacturers and private payers have expressed interest in novel pricing models that more closely link a drug’s price to its value. Indication-based pricing,… Read More

Mobile Health Innovation and Interagency Coordination

Annals of Health Law, Vol. 26, Issue 22
by Rachel E. Sachs (Academic Fellow Alumna)

From the paper: An app that can tell when a phone’s owner is having a seizure.1 A device that transforms a phone into a mobile EKG machine.2 An app that helps patients track their moles over time—and… Read More

Battle over drug prices shifts back to the states

The Hill, October 11, 2017
by By Rachel Roubein, quoting Rachel E. Sachs (Academic Fellow Alumna)

From the article: President Trump has derided pharmaceutical companies as “getting away with murder,” but there’s been little action in Washington to rein in the costs of prescription… Read More

Congress keeps the heat on 340B

Politico, October 10, 2017
by By Sarah Karlin-Smith, citing work by Rachel E. Sachs (Academic Fellow Alumna)

From the article: The House Energy and Commerce Oversight Subcommittee will probe Wednesday into how hospitals and health clinics participating in the 340B discount drug program are using the… Read More

Organ Donor Research: Overcoming Challenges, Increasing Opportunities

JAMA, October 10, 2017
by James F. Childress, reviewing report co-authored by I. Glenn Cohen (Faculty Director)

From the article: A substantial gap exists between the need for organ transplants and the number of transplants performed each year in the United States. In 2016, 27 630 organs were transplanted… Read More

‘That should be illegal’

Business Insider, October 10, 2017
by By Lydia Ramsey, quoting Rachel E. Sachs (Academic Fellow Alumna)

From the article: Allergan, the drugmaker behind Botox, is using a tricky workaround to protect patents on one of its drugs — and lawmakers aren't exactly happy about it.  The deal, which… Read More

ICER Weekly View 10-06-17

ICER, October 6, 2017
by Mitchell Stein, featuring work by Rachel E. Sachs (Academic Fellow Alumna)

From the review: Medicaid’s “best price rule” has long been held up as an obstacle to value pricing – health policy/legal experts take a look and conclude that “the best-price… Read More

Axios Vitals post from October 4

Axios, October 4, 2017
by By Sam Baker, featuring work by Rachel E. Sachs (Academic Fellow Alumna)

From the post: Medicaid and value-based drug deals: New research casts some doubt on the pharmaceutical industry's claim that Medicaid's "best-price" rule inhibits its ability to create contracts… Read More

Letter to Allergan plc

The House of Representatives Committee on Oversight and Government Reform, October 3, 2017
by By Trey Gowdy, Elijah E. Cummings, Dennis A. Ross, and Peter Welch, citing blog post by Rachel E. Sachs (Academic Fellow Alumna)

From the letter: On September 8, 2017, your company announced the trans r of six patents related to its Restasis drug to the Saint Regis Mohawk tribe. 1 The unconventional maneuver has received considerable… Read More

Absent federal action, states take the lead on curbing drug costs

The Washington Post, September 29, 2017
by By Shefali Luthra, quoting Rachel E. Sachs (Academic Fellow Alumna)

From the article: Critics see these tailored efforts as falling short or potentially opening other loopholes. Requiring companies to report prices past a certain threshold, for example, might encourage… Read More

Why Chicago’s soda tax fizzled after two months — and what it means for the anti-soda movement

Washington Post, October 10, 2017
by Caitlin Dewey

About two months after the country’s largest soda tax went into effect, embattled lawmakers in Cook County, Ill. — the home of Chicago — have decided to repeal it. The tax has… Read More

In New Test for Obamacare, Iowa Seeks to Abandon Marketplace

New York Times, October 10, 2017
by Abby Goodnough

WASHINGTON — With efforts to repeal the Affordable Care Act dead in Congress for now, a critical test for the law’s future is playing out in one small, conservative-leaning state. Iowa is anxiously… Read More

Washington Is Latest State To Sue Trump Administration Over Contraception Mandate Rollback

Kaiser Health News, October 10, 2017

KHN Morning Briefing: Summaries of health policy coverage from major news organizations Washington state Attorney General Bob Ferguson says that the new rules violate the First Amendment by “requiring… Read More

Trump’s Cuts to Health Law Enrollment Efforts Are Hitting Hard

New York Times, October 9, 2017
by Robert Pear

WASHINGTON — Michigan Consumers for Health Care, a nonprofit group, has enrolled thousands of people in health insurance under the Affordable Care Act and was honored last year as one of the nation’s… Read More

In Puerto Rico, Health Concerns Grow Amid Lack of Clean Water, Medical Care

The Wall Street Journal, October 4, 2017
by Daniela Hernandez

In the aftermath of Hurricane Maria, many Puerto Ricans are grappling with growing health concerns due to a lack of reliable access to medical care, supplies and clean water. Maggie Reuteman,… Read More

IBM to Congress

STAT, October 4, 2017
by Casey Ross and Ike Swetlitz

To the public, IBM trumpets its Watson supercomputer as the next big thing in medicine, a new kind of machine that melds human expertise with digital speed to give patients personalized… Read More

Why Price’s conservative imprint on HHS is likely to endure

Politico, October 3, 2017
by Paul Demko, David Pittman, and Brianna Ehley

Tom Price may be gone as Health and Human Services secretary, but his efforts to put a conservative stamp on the $1.1 trillion agency, from promoting faith groups to scrapping Obamacare implementation,… Read More

Trump Administration Set to Roll Back Birth Control Mandate

New York Times, October 5, 2017
by Robert Pear

WASHINGTON — The Trump administration is poised to roll back the federal requirement for employers to include birth control coverage in their health insurance plans, vastly expanding exemptions for… Read More

CHIP Funding Measure Passes Through Committees, But It’s Not Smooth Sailing Ahead For Bill

Kaiser Health News, October 5, 2017

KHN Morning Briefing: Summaries of health policy coverage from major news organizations The provisions Republicans want to add to reauthorize funds for the Children's Health Insurance Program… Read More

House Budget Plan Calls For Deep Cuts To Medicaid, Overhaul Of Medicare

Kaiser Health News, October 5, 2017

KHN Morning Briefing: Summaries of health policy coverage from major news organizations But Republicans are not actually planning to impose any of those cuts which are limited to nonbinding promises.… Read More

California Bill Would Compel Drugmakers To Justify Price Hikes

NPR, October 4, 2017
by April Dembosky

Insurers, hospitals and health advocates are waiting for Gov. Jerry Brown to deal the drug lobby a rare defeat, by signing legislation that would force pharmaceutical companies to justify big… Read More

House passes 20-week abortion ban, citing disputed science of ‘fetal pain’

STAT, October 3, 2017
by Lev Facher

[...] The issue of fetal pain, scientifically, is relatively unsettled. The Journal of the American Medical Association wrote in 2005: “Evidence regarding the capacity for fetal pain is limited but… Read More

With Health Care At Pivotal Crossroads, HHS Pick Could Signal What Path Trump Wants To Take

Kaiser Health News, October 2, 2017

KHN Morning Briefing: Summaries of health policy coverage from major news organizations Some of the names getting attention are Centers for Medicare & Medicaid Services chief Seema Verma, Fla.… Read More

U.S. states are waging a civil war over donated livers. Will a new proposal finally resolve it?

STAT, October 2, 2017
by Casey Ross

[...] All were writing in a response to a proposal that would change the geographic lines that determine access to donor livers in communities across the United States. The public comment period,… Read More

9 million kids get health insurance under CHIP. Congress just let it expire.

Washington Post, October 1, 2017
by Valerie Strauss

Congress just allowed the Children’s Health Insurance Program, which provided low-cost health insurance to 9 million children, to expire. If action is not taken soon to restore the funding, the effects… Read More

Thousands Rally in Dublin Against Ireland’s Abortion Ban

New York Times, September 30, 2017
by Megan Specia

Thousands of people marched in Dublin on Saturday to demand an end to the country’s constitutional ban on abortion, one of the strictest such laws in the Western world. The March for Choice is an… Read More

WHO tells governments to reject Philip Morris-funded smoking foundation

Reuters, September 28, 2017
by Tom Miles

GENEVA (Reuters) - The World Health Organization told governments on Thursday not to get involved in a foundation funded by tobacco firm Philip Morris International to look at ways of reducing the harm… Read More

Massachusetts AG launches probe of addiction treatment fraud

STAT, September 29, 2017
by David Armstrong

he Massachusetts attorney general’s office is investigating a far-reaching insurance scheme that recruited drug users and sent them to treatment centers in other states to exploit their benefit payments,… Read More

Now What? 5 Looming Challenges For The Affordable Care Act

NPR, September 26, 2017
by Julie Rovner

Republicans officially pulled the plug on their last-ditch effort to repeal and replace the Affordable Care Act on Tuesday. "We don't have the votes," said Sen. Bill Cassidy, R-La., after a closed-door… Read More

Lawmakers ‘On The Verge’ Of Striking Bipartisan Deal To Stabilize Marketplaces, Schumer Vows

Kaiser Health News, September 29, 2017

KHN Morning Briefing: Summaries of health policy coverage from major news organizations Sens. Lamar Alexander (R-Tenn.) and Patty Murray (D-Wash.), the chairman and ranking member of the Health, Education,… Read More

Here’s how the Trump administration is hurting enrollment in Obamacare

Washington Post, September 28, 2017
by Philip Bump

At its heart, the Affordable Care Act — Obamacare — is about figuring out how to pay to provide more people with insurance coverage. Before the policy was enacted, insurers balked at covering… Read More

Harvard Health Law Society Mixer (10/3, 7 PM)
Harvard Law School

Deadline: October 03, 2017

October 3, 7PM - Student Orgs Room (WCC 2063), Wasserstein Hall, Harvard Law School Come eat Thai food with the Harvard Heath Law Society and learn about health law opportunities at Harvard! If you have… Read More

Paternalism, reasonableness, and neutrality: a response to commentators

Journal of Medical Ethics, September 2017, Vol. 43 No. 9
by Frances Kamm (former Senior Fellow)

From the article (from the commentary on Frances Kamm's earlier article, "Advanced Care and End of Life Care: Some Cautionary Suggestions." I thank the commentators for their consideration of my views… Read More

Some States Make It Hard For Teen Moms To Get Pain Relief In Childbirth

NPR, September 28, 2017
by Esther Honig

[...] Throughout the U.S., minors are generally required to have permission from their parents or legal guardian before they can receive most medical treatment. However, each state has established… Read More

More than 25 million unsafe abortions performed worldwide each year

STAT, September 27, 2017
by Megan Thielking

[...]  Here’s a look at the findings: There are 55.7 million abortions every year across the globe. About 55 percent of those were considered safe abortions. Almost all abortions in developed… Read More

McConnell Says Republicans Are Giving Up on Health Bill

New York Times, September 26, 2017
by Thomas Kaplan

WASHINGTON — Senator Mitch McConnell on Tuesday officially pulled the plug on the latest plan to repeal the Affordable Care Act, telling senators they will not vote on the measure and effectively… Read More

After Collins Officially Declares Opposition, Passing Health Bill Becomes ‘Nearly Impossible’

Kaiser Health News, September 26, 2017

KHN Morning Briefing: Summaries of health policy coverage from major news organizations Sen. Susan Collins (R-Maine) joins Sens. John McCain (R-Ariz.) and Rand Paul (R-Ky.) in opposition of Republicans'… Read More

With Clock Ticking, Senators Tweak Health Plan To Shift Money To Reluctant Senators’ States

Kaiser Health News, September 25, 2017

KHN Morning Briefing: Summaries of health policy coverage from major news organizations The changes would send money to Alaska and Maine, homes of Republican Sens. Lisa Murkowski and Susan Collins.… Read More

Movie’s Ads Protest Rules Restricting Gay Men From Donating Blood

New York Times, September 24, 2017
by Brooks Barnes

LOS ANGELES — The last “Saw” movie, released by Lionsgate in 2010, was advertised as “the final chapter.” But you didn’t think a franchise with roughly $1 billion in… Read More

Sunday Hours: Obamacare Website To Be Shut Down For Portion of Most Weekends

Kaiser Health News, September 22, 2017
by Phil Galewitz

The Trump administration plans to shut down the federal health insurance exchange for 12 hours during all but one Sunday in the upcoming open enrollment season. The shutdown will occur from 12 a.m. to… Read More

Call for Papers: Second Annual Regional Health Law Works-in-Progress Retreat
Seton Hall Law School’s Center for Health & Pharmaceutical Law & Policy

Deadline: November 17, 2017

Seton Hall Law School’s Center for Health & Pharmaceutical Law & Policy is pleased to announce the Second Annual Regional Health Law Works-in-Progress Retreat, which will be… Read More

Christie outlines $200M for opioids while waiting on Trump

ABC News, September 19, 2017
by Michael Catalini

As Gov. Chris Christie waits for President Donald Trump to declare the opioid epidemic a national emergency, he announced Tuesday that he'll spend another $200 million in New Jersey to… Read More

For GOP, Political Incentive Is ‘As Much Of A Reason As The Substance’ To Pass Repeal Bill

Kaiser Health News, September 21, 2017

KHN Morning Briefing: Summaries of health policy coverage from major news organizations The driving force behind this last-ditch attempt for many lawmakers it the simple fact that they promised their… Read More

Majority Of States Would Lose ‘Jaw-Dropping’ Amounts Of Funding Under Graham-Cassidy Bill

Kaiser Health News, September 21, 2017

KHN Morning Briefing Summaries of health policy coverage from major news organizations A new study by Avalere Health finds that red states would disproportionately benefit, while 34 states would be hit… Read More

Insurance Industry Comes Out Against Graham-Cassidy Trumpcare Bill

Forbes, September 20, 2017
by Bruce Japsen

The nation’s Blue Cross Blue Shield plans and the powerful insurance lobby America's Health Insurance Plans on Wednesday joined mounting opposition from health-care providers, patient advocates… Read More

Anger as Brazilian judge backs anti-gay ‘therapy’

BBC News, September 20, 2017

Brazilian activists and celebrities have condemned a court ruling that approves a "cure" for gay people. Waldemar de Carvalho, a federal judge in the capital Brasilia, backed a psychologist who had her… Read More

Your Money or Your Patient’s Life? Ransomware and Electronic Health Records

Annals of Internal Medicine, September 19, 2017
by By I. Glenn Cohen (Faculty Director), Sharona Hoffman, and Eli Y. Adashi

The mugger's demand “Your money or your life” is a familiar one. However, in an era of vast hospital computer networks and electronic health records, a novel risk to worry about is, “Your… Read More

41 States To Investigate Pharmaceutical Companies Over Opioids

NPR, September 19, 2017
by Yuki Noguchi

The attorneys general of 41 U.S. states said Tuesday that they're banding together to investigate the makers and distributors of powerful opioid painkillers that have, over the past decade, led to… Read More

Attorneys General in 37 States Urge Insurance Industry to Do More to Curb Opioid Epidemic

ProPublica, September 18, 2017
by Charles Ornstein

ttorneys general for 37 states sent a letter Monday to the health insurance industry’s main trade group, urging its members to reconsider coverage policies that may be fueling the opioid… Read More

As Federal Government Cuts Obamacare Ads, Private Insurer Steps Up

NPR, September 18, 2017
by Alison Kodjak

Open enrollment for Affordable Care Act insurance doesn't start for another six weeks. But the quirky insurance startup Oscar Health is launching an ad campaign Monday aimed at getting young… Read More

GOP Says It’s Close On Graham-Cassidy Bill, But Those Last Votes Have Always Been A Struggle

Kaiser Health News, September 18, 2017

KHN Morning Briefing: Summaries of health policy coverage from major news organizations The measure from Sens. Bill Cassidy (R-La.) and Lindsey Graham (R-S.C.) is the party's last-ditch effort… Read More

Rural Hospitals Struggle To Stock Expensive Drugs That Could Save Lives

NPR, September 15, 2017
by Sarah Jane Tribble

[...] Langston fears others could die because of an unintended bias against rural hospitals built into the U.S. health law. An obscure Obamacare provision forces rural hospitals like Langston's to… Read More

FDA Law SSRN Reading List - August 2017

Objective Intent Blog, September 14, 2017
by By Erika Lietzan, highlighting work by Rachel E. Sachs (Academic Fellow Alumna)

From the post:  Rachel Sachs, Administering Health Information (forthcoming in Cardozo Law Review).  Professor Sachs (Washington University, in St. Louis) explores the potential for… Read More

FDA Law SSRN Reading List - August 2017

Objective Intent Blog, September 14, 2017
by Erika Lietzan, highlighting work by Rachel E. Sachs (Academic Fellow Alumna)

From the post:  Rachel Sachs, Administering Health Information (forthcoming in Cardozo Law Review).  Professor Sachs (Washington University, in St. Louis) explores the potential for… Read More

‘Whatever it takes’

STAT, September 13, 2017
by Max Blau

[...] Hospital administrators, long accustomed to the world of hiring incentives, are making more enticing offers to nurses than ever before. Five-figure signing bonuses have replaced four-figure… Read More

Why a Drug Company Is Selling Patents to a Native American Tribe

Gizmodo, September 12, 2017
by By Ryan F. Mandelbaum, quoting Rachel E. Sachs (Academic Fellow Alumna)

[...] There is concern that this act may be precedent setting, and other companies may also try and transfer patents to Native American tribes to get around these patent lawsuits. Rachel Sachs,… Read More

Call for Papers: 2018 Annual Health Law Conference: Diseases of Despair: The Role of Law and Policy
Center for Health Policy and Law, Northeastern University School of Law

Deadline: November 15, 2017

In 2015, Princeton professors Anne Case and Angus Deaton wrote a groundbreaking paper that revealed a shocking increase in midlife mortality among white, non-Hispanic Americans between 1999… Read More

Allergan’s deal with the Mohawks raises troubling questions about the future of generics

STAT , September 11, 2017
by By Ed Silverman, quoting Rachel E. Sachs (Academic Fellow Alumna)

From the article: [...] Legal experts, however, say that tribal sovereignty may also thwart generic drug makers from filing a conventional lawsuit. If so, the ramifications may be far-reaching and ominous… Read More

Democrats Worry Compromising For Short-Term Wins Will Lead To Long-Term Evisceration Of Law

Kaiser Health News, September 11, 2017

KHN Morning Briefing: Summaries of health policy coverage from major news organizations Democratic lawmakers want the insurer subsidies to be paid. But to get that, they have to give up on something… Read More

How to Protect a Drug Patent? Sell it to a Native American Tribe

New York Times, September 8, 2017
by Katie Thomas

The drugmaker Allergan announced Friday that it had transferred its patents on a best-selling eye drug to the Saint Regis Mohawk Tribe in upstate New York — an unusual gambit to protect the drug… Read More

FDA Accuses EpiPen Maker of Failing to Investigate Malfunctions

New York Times, September 7, 2017
by Katie Thomas

The Food and Drug Administration this week accused the drugmaker Pfizerof failing to properly investigate reports of malfunctioning EpiPens, including incidents when patients died or became… Read More

Judge opens door for lawsuit over girl declared brain dead

ABC News, September 7, 2017
by Paul Elias, Associated Press

A California judge ruled that a teen girl who was declared brain dead more than three years ago after a tonsillectomy may technically still be alive, allowing a malpractice lawsuit against the… Read More

A Tone Shift On Capitol Hill As Lawmakers Try To Come Up With Bipartisan Health Solution

Kaiser Health News, September 6, 2017

KHN Morning Briefing: Summaries of health policy coverage from major news organizations Republicans are now in the position to have to work with Democrats so make sure the marketplace doesn't… Read More

Kentucky Could Become The Only State Without A Clinic That Performs Abortions

NPR, September 6, 2017
by Sarah McCammon

Kentucky is down to only one clinic that performs abortions: the EMW Women's Surgical Center in Louisville. A trial kicking off Wednesday morning in federal court in Louisville… Read More

Deporting ‘Dreamers’ May Hit Home Health Care Especially Hard

New York Times, September 6, 2017
by Noam Scheiber and Rachel Abrams

When the Trump administration announced on Tuesday that it would endan Obama-era program that shielded young undocumented immigrants from deportation, Sherwin Sheik quickly sized up the potential… Read More

Influence, integrity, and the FDA: An ethical framework

Science, Sep 1, 2017: Vol. 357, Issue 6354, pp. 876-877.
by Spencer Phillips Hey, I. Glenn Cohen (Faculty Director), Eli Y. Adashi, & Aaron S. Kesselheim

Summary: Among the core missions of the U.S. Food and Drug Administration (FDA) are protecting public health by assuring the safety and efficacy of drugs, biologics, and medical devices and advancing public… Read More

Clinical Ethics Fellowship
Center for Medical Ethics & Health Policy at Baylor College of Medicine

Deadline: November 13, 2017

General Description: This competitive 2-year fellowship offers the opportunity to train with the Center’s nationally renowned faculty and staff who lead premier Clinical Ethics Consultation… Read More

Tenure-Track/Tenured Health Law Position
Indiana University Robert H. McKinney School of Law

Deadline: September 25, 2017

The Indiana University Robert H. McKinney School of Law invites applications for a tenure-track/tenured faculty position. We invite applications from entry-level and experienced scholars. The position… Read More

Artificial wombs are coming. They could completely change the debate over abortion.

Vox, August 23, 2017
by I. Glenn Cohen (Faculty Director)

From the article: There’s a scientific development on the horizon that could upend the abortion debate: artificial wombs. The research remains preliminary, but in April a group of scientists at the… Read More

Obamacare survives its latest threat: Bare counties

POLITICO Pulse, August 21, 2017
by Dan Diamond, quoting Rachel E. Sachs (Academic Fellow Alumna)

From the article:  Trump quietly signs FDA reauthorization bill. The president didn't hold a signing ceremony on Friday, even though the bill has been one of the few major pieces of legislation… Read More

What you missed while following Charlottesville: The opioid emergency

Axios, August 18, 2017
by Erica Pandey, quoting Rachel E. Sachs (Academic Fellow Alumna)

From the article: The opioid emergency "The opioid crisis is an emergency, and I'm saying officially, right now, it is an emergency ... It's a national emergency. We're going to spend a lot… Read More

New Serious Illness Program Design and Implementation Framework

Coalition to Transform Advanced Care (C-TAC), August 17, 2017
by Khue Nguyen, Theresa Schmidt, Robin Whitney, Gary Bacher, Janice Bell, Sibel Ozcelik (Lead Authors)

As part of the Project on Advanced Care and Health Policy, the Petrie-Flom Center hosted two convenings on Critical Pathways to Improved Care for Serious Illness.  Through roundtable discussions… Read More

Questions About The FDA’s New Framework For Digital Health

Health Affairs Blog, August 16, 2017
by Nathan G. Cortez, Nicolas Terry, and I. Glenn Cohen (Faculty Director)

From the article: In June 2017, the new Food and Drug Administration (FDA) commissioner Scott Gottlieb pre-announced his agency’s Digital Health Innovation Action Plan that indicates… Read More

The One Time Congress Let the Public Comment on an Upcoming Bill

Pacific Standard, August 14, 2017
by Francie Diep, quoting Rachel E. Sachs (Academic Fellow Alumna)

[...] Congress doesn't typically ask for public comments on the bills it's considering. But, in January of 2015, the House Energy and Commerce Committee did just that, for a first draft of the 21st… Read More

Bernie Sanders Tells Big Pharma

International Business Times, August 7, 2017
by Josh Keefe, quoting Rachel E. Sachs (Academic Fellow Alumna)

[...] Other experts told IBT federal support of drug development goes well beyond just funding research. “It’s not so much the money we are actually spending through NIH. We are providing huge… Read More

Administering Health Innovation

Cardozo Law Review, Forthcoming 2018
by Rachel E. Sachs (Academic Fellow Alumna)

Abstract Scholars and policymakers have recently begun to focus on the role federal agencies charged with health-related missions can play in the development of innovative health technologies and promotion… Read More

Who’s Actually Using ‘Right-To-Try’ Laws?

RAPS, August 4, 2017
by Zachary Brennan, quoting Rachel E. Sachs (Academic Fellow alumna)

'The record with state-level right-to-try laws also suggests lackluster interest from industry. "It's telling that although 37 states have adopted these laws, when asked to provide examples of… Read More

Academic Fellow Alum Matthew J. B. Lawrence Joins Faculty at Dickinson Law (Penn State)

Dickinson Law, Penn State University, August 1, 2017

Matthew J.B. Lawrence has joined the faculty of Penn State’s Dickinson Law as assistant professor of law. An expert in the fields of health law and administrative law, Lawrence will teach Health… Read More

Postdoctoral Fellowship
Sydney Law School

Deadline: September 10, 2017

OVERVIEW The University of Sydney Law School Postdoctoral Fellowship aims to attract an outstanding early career researcher to the University of Sydney to contribute to and enhance the research strengths… Read More

Artificial Wombs and Abortion Rights

The Hastings Center Report, July 27, 2017
by I. Glenn Cohen (Faculty Director)

Abstract: In a study published in late April in Nature Communications, the authors were able to sustain 105- to 115-day-old premature lamb fetuses—whose level of development was comparable to that… Read More

Locked Out Of Asia, Americans Are Turning To Eastern Europe To Hire Gestational Surrogates

HuffPost, July 25, 2017
by Sarah Elizabeth Richards, quoting I. Glenn Cohen (Faculty Director)

From the article: [...] While it’s impossible to know “what’s presented to you versus what’s really occurring,” Harvard Law School Professor I. Glenn Cohen said, fertility… Read More

Judge Offers Inmates Reduced Sentences in Exchange for Vasectomy

NBC News, July 21, 2017
by Kalhan Rosenblatt, quoting I. Glenn Cohen (Faculty Director)

From the article: [... I.] Glenn Cohen, a professor at Harvard Law School, said the program was a "bad policy," and pointed to prior court rulings, which set a precedent that could make Benningfield's… Read More

Petrie-Flom Welcomes New Senior Fellow in Law and Applied Neuroscience!

Petrie-Flom Center, July 21, 2017

We’re excited to announce our 2017–2018 Senior Fellow in Law and Applied Neuroscience, Francis X. Shen! Project on Law and Applied Neuroscience The Project on Law and Applied Neuroscience,… Read More

Fulbright Visiting Research Chair in Health Law, Policy and Ethics
University of Ottowa, Centre for Health Law, Policy and Ethics

Deadline: August 01, 2017

OVERVIEW Hosted at the Centre for Health Law, Policy and Ethics, the Chairholder will join a vibrant and growing community of scholars who are working on cutting-edge issues in health… Read More

Assistant or Associate Professor
Department of Medical History and Bioethics, University of Wisconsin-Madison

Deadline: November 24, 2017

OVERVIEW The University of Wisconsin-Madison seeks applications for a tenure-track faculty position in the Department of Medical History and Bioethics at the rank of assistant or associate professor. We… Read More

Staff Attorney
The Educational Fund to Stop Gun Violence

Deadline: Open until filled

Staff Attorney The Educational Fund to Stop Gun Violence (Ed Fund) is a 501(c)(3) organization that makes communities safer by translating research into policy. The Ed Fund achieves this by engaging in… Read More

Public Health Fellowship in Government
American Public Health Association

Deadline: August 14, 2017

The Fellowship in Government provides a unique public policy learning experience, demonstrates the value of science-government interaction and enhances public health science and practical knowledge in… Read More

Katherine Kraschel Joins Solomon Center as New Executive Director

Yale Law School, July 7, 2017

From the article: “I am delighted to welcome Katie to the Solomon Center,” said Professor Abbe R. Gluck ’00, Faculty Director for the Solomon Center. “Having worked with her for… Read More

Public Participation in Drafting of the 21st Century Cures Act

The Journal of Law, Medicine & Ethics, July 14, 2017
by Thomas J. Hwang, Rachel E. Sachs (Academic Fellow Alumna), Aaron S. Kesselheim

Abstract The 21st Century Cures Act is a major act of legislation that contains numerous changes to drug and device regulation. The House of Representatives passed the Act after considerable interest group… Read More

‘Sperminator’ Ari Nagel spreads more seed on recent Israel visit

Times of Israel, July 6, 2017
by Renee Ghert-Zand, quoting I. Glenn Cohen (Faculty Director)

From the article:  [...] According to Harvard law professor and bioethics expert I. Glenn Cohen, there is no law that prohibits Nagel’s sperm donations. At the same time, there are not… Read More

FDA to Speed Review of Generic Drug Applications Until It’s Approved Three of Them

STAT News, June 27, 2017
by Rebecca Robins, quoting Rachel E. Sachs (Academic Fellow Alumna)

From the article: The Food and Drug Administration on Tuesday moved to try to spur more competition in the market for generic drugs, an effort aimed at driving down prices. In a policy change,… Read More

Post-Doctoral Research Position
Stanford Center for Biomedical Ethics (SCBE)

Deadline: August 01, 2017

This position is available as part of the Stanford Training Program in Ethical, Legal, and Social Implications (ELSI) Research and at the Center for Integration of Research on Genetics and Ethics (CIRGE).… Read More

Associate Director of Research
Consortium on Law and Values in Health, Environment, & the Life Sciences, University of Minnesota

Deadline: Open until filled

Opportunity The University of Minnesota’s Consortium on Law and Values in Health, Environment & the Life Sciences (consortium.umn.edu) is seeking a highly qualified individual to collaborate… Read More

The FDA May Move to Shorten That Grim List of Side Effects in Every Drug Ad

STAT News, June 28, 2017
by Megan Thielking, quoting Holly Fernandez Lynch (Executive Director)

From the article: Warning: Watching TV drug ads may put you to sleep. That’s no surprise to many of us who’ve heard about the countless ways prescription drugs can harm us. But now, the Food… Read More

Meet The People Doing Poop Transplants The Government Doesn’t Want Them To

Buzzfeed, June 28, 2017
by Nidhi Subbaraman, quoting Rachel E. Sachs (Academic Fellow Alumna)

From the article: Some scientists and legal experts have suggested that poop be regulated like a tissue — something that was derived from the body, and therefore subject to less stringent… Read More

The Case for Giving Health-Care Consumers a ‘Nudge’

Wall Street Journal, June 25, 2017
by Lisa Ward, interviewing Christopher T. Robertson (Academic Fellow Alumnus)

The Case for Giving Health-Care Consumers a ‘Nudge:’ A law professor argues that people will make better choices if they’re asked the right way For example, some states encourage child… Read More

Panel: Weighing the Risks of Randomized Controlled Trials and Alternatives

The New York Academy of Sciences, June 21, 2017
by Panel featuring Holly Fernandez Lynch (Executive Director), Amrit Ray, Matthew Rotelli, Steve Usdin, and Robert Walker

On June 21, 2017, Executive Director Holly Fernandez Lynch participated in a panel discussion on "Weighing the Risks of Randomized Controlled Trials and Alternatives," which was part of the conference… Read More

Turning to the States to Solve the National Problem of Drug Pricing

STAT News, June 20, 2017
by Meghana Keshavan, quoting Rachel E. Sachs (Academic Fellow Alumna)

From the article: Drug pricing is a national problem. So a nonprofit wants to help hand off some of that burden to the states. The National Academy for State Health Policy just launched a new center, called… Read More

At Drug Hearing, Senators Discuss Meanings of Price and Value - and Debate Health Reform

Health Affairs Blog, June 20, 2017
by Rachel E. Sachs (Academic Fellow Alumna)

From the article by Rachel E. Sachs, (Academic Fellow Alumna): On Tuesday, June 13, the Senate Health, Education, Labor, & Pensions (HELP) Committee held the first of three planned hearings… Read More

Book Review: I Contain Multitudes - The Microbes Within us and a Grander View of Life

Journal of Law and the Biosciences, June 2017
by Rachel E. Sachs (Academic Fellow Alumna)

From the review by Rachel E. Sachs: Ed Yong's I Contain Multitudes: The Microbes Within us and a Grander View of Life is a thoughtful, readable, and even humorous look at the rapidly evolving… Read More

Trying to Keep up with the Health Care Debate on the Hill? Follow These Folks on Twitter

STAT News, June 13, 2017
by Megha Satyanarayana, featuring Rachel E. Sachs (Academic Fellow Alumna)

From the article: The GOP effort to repeal and replace Obamacare is picking up steam again as the Senate works on its bill behind closed doors. How to keep track of it all? Here are a few folks to follow on… Read More

This Pharma Company Won’t Commit to Fairly Pricing a Zika Vaccine You Helped Pay For

The Huffington Post, June 9, 2017
by Alexander C. Kaufman, quoting Rachel E. Sachs (Academic Fellow Alumna)

From the article: “The incentives for any one company to raise its prices or engage in questionable conduct are quite high, while the incentives for the industry as a whole to corral and police its… Read More

ERISA: A Bipartisan Problem For The ACA And The AHCA

Health Affairs Blog, June 2, 2017
by Abbe R. Gluck, Allison K. Hoffman (Academic Fellow Alumna), and Peter D. Jacobson

From the post: The Supreme Court has once again been called on to mediate the boundaries of a far-reaching, infamously complex, federal employee benefits law. And once again this law may have… Read More

From the Technical to the Personal: Teaching and Learning Health Insurance Regulation and Reform

Saint Louis University Law Journal, Vol. 61, no. 411
by Allison K. Hoffman (Academic Fellow Alumna), Whitney A. Brown, and Lindsay Cutler

From the article: In the Fall of 2016, I taught Health Law and Policy for the fourth consecutive semester. In this repeat loop, one thing has become increasingly clear: the aspect of this survey course… Read More

Q&A with Faculty Scholar Rachel Sachs

Institute for Public Health at Washington University , May 23, 2017
by Interview featuring Rachel Sachs (Academic Fellow Alumna)

From the interview: Rachel Sachs, associate professor, School of Law, is a scholar of innovation policy whose work explores the interaction of intellectual property law, food and drug regulation,… Read More

How a Supreme Court ruling on printer cartridges could have a big impact on drug prices

STAT News, May 30, 2017
by Meghana Keshavan, quoting Rachel Sachs (Academic Fellow Alumna)

From the article: A Supreme Court ruling on international printer cartridge sales could have major implications for, of all things, drug pricing and global health. The case in question involves patents,… Read More

Legal Roundtable: Discussing abortion restrictions, health care, Supreme Court developments and more

St. Louis Public Radio, May 30, 2017
by Kelly Moffitt, featuring Rachel Sachs (Academic Fellow Alumna)

From the radio episode: On Tuesday’s St. Louis on the Air, Legal Roundtable panel returned to discuss pressing issues of the law. They discussed a number of topics, starting with national issues… Read More

Call for Papers: Data-driven Health Care Conference
Ewha Institute for Biomedical Law & Ethics, South Korea

Deadline: June 15, 2017

1.   Conference Description The Ewha Institute for Biomedical Law & Ethics (EIBLE) is seeking submissions for its annual conference to be held on September 23, 2017 in Seoul. This year’s… Read More

New Issue of the Journal of Law and the Biosciences

Journal of Law and the Biosciences (JLB), Vol. 4, No. 1, April 2017

The Journal of Law and the Biosciences, the open-access journal launched in 2014 by the Petrie-Flom Center and Harvard Law School in partnership with Duke University and Stanford University, has… Read More

The Sean Pendergast Show with Dr. Glenn Cohen, Harvard Law Professor

The TJ Show, AMP Radio 103.3 FM, May 28, 2017
by Interviewing I. Glenn Cohen (Faculty Director)

Harvard Law Professor [I. Glenn Cohen (Faculty Director)] joins Sean to discuss a study he and a Harvard group did on player safety in the NFL, how the game can be made more safe, and the future of… Read More

Regulating Research with Biospecimens under the Revised Common Rule

The Hastings Center Report, May/June 2017
by Holly Fernandez Lynch (Executive Director) and Michelle N. Meyer (Academic Fellow Alumna)

From the paper: Since 2011, the research community had waited with bated breath as regulators contemplated for the first time bringing secondary research with nonidentifiable biospecimens under the Common… Read More

Reading the Fine Print in DNA Kits

NBC Boston, May 23, 2017
by Interview featuring I. Glenn Cohen (Faculty Director)

DNA kits are very popular these days with people wanting to know what countries their ancestors came from. But before seeking out the secrets of your family tree, make sure you read the fine print. Watch… Read More

Roster exemptions for players with concussions could draw vote from NFL owners

USA Today, May 22, 2017
by Tom Pelissero, citing Petrie-Flom's report

From the article: A short-term injured reserve for players diagnosed with a concussion was among 76 recommendations included in a Harvard Law School report — based on research funded by the NFL Players… Read More

Why Successful Post-Season Runs Make People Lose Their Minds About Concussions

Forbes, May 16, 2017
by Lee Igel, citing Petrie-Flom's report

From the article: Were either or both Crosby and Harden suffering the effects of a head injury, yet seeing game action? Appearances can be deceiving. In addition to medical personnel assessing a player's… Read More

How does the NFL stack up with health care?

ESPN, May 22, 2017
by Michael McCann, citing Petrie-Flom's report

Sports Illustrated legal analyst Michael McCann joins OTL to discuss the NFL's health care for its players. Watch video here! Read More

FDA User Fee Reauthorization Clears Hurdle In Senate With Bipartisan Support

Health Affairs Blog, May 15, 2017
by Rachel Sachs (Academic Fellow Alumna)

From the article: On Thursday, May 11, the Senate Committee on Health, Education, Labor and Pensions marked up the proposed Food and Drug Administration (FDA) user fee reauthorization bill and… Read More

Angel investors are the first stop in a new era of drug development

Newsworks, May 11, 2017
by Elana Gordon, quoting Rachel Sachs

From the article: So is this really the best way to develop new healthcare technologies and therapies? "So there are pros and there are cons," said Rachel Sachs, a law professor at Washington University in… Read More

The Trump administration could bring down drug prices. But it would take guts

STAT News, May 15, 2017
by Ed Silverman, quoting Rachel Sachs (Academic Fellow Alumna)

From the article: “If Price and [President] Trump are interested in lower-priced drugs, they have access to a tool that enables them to do that,” explained Rachel Sachs, an associate professor… Read More

The White House budget director dropped a hint about how Trump could bring drug prices down

Washington Post, May 12, 2017
by Carolyn Y. Johnson, quoting Rachel Sachs (Academic Fellow Alumna)

From the artcile: Trump has repeatedly said that drug prices are too high but has often suggested that increased bidding would be the best way to bring down prices. It has been unclear how that… Read More

New FDA Chief Scott Gottlieb: Medication Reformer or Big Pharma Shill?

The Fix, May 18, 2017
by Paul Gaita, quoting Rachel Sachs (Academic Fellow Alumna)

From the article: Gottlieb's position has earned cautious approval from medical industry observers like Washington University associate professor Rachel Sachs, who wrote, "As someone who understands… Read More

New York state wants its prescription drug money back—or else

USA Today, May 18, 2017
by Julie Appleby, quoting Rachel Sachs (Academic Fellow Alumna)

From the article: New York’s Medicaid program, for example, has seen its drug spending rise on average 8% each year over the past three years, after taking into account existing rebates. The… Read More

Faculty Books in Brief—Spring 2017

Harvard Law Bulletin, May 18, 2017
by Featuring book by I. Glenn Cohen (Faculty Director), Holly Fernandez Lynch (Executive Director), & Christopher T. Robertson (Academic Fellow Alumnus)

From the article: Cohen, faculty director of the Petrie-Flom Center; Lynch, the center’s executive director; and Robertson, a professor at University of Arizona’s College of Law, edit essays… Read More

The NFL May Make A Smart Change To Its IR Rules

Deadspin, May 17, 2017
by Dom Cosentino, citing Petrie-Flom's report

From the article: What the NFL could use is a short-term disabled list not unlike what exists in Major League Baseball. Right now, the NFL’s active and inactive lists function sort of like… Read More

Babies from skin cells? New fertility technology raises ethical questions

The Current, May 19, 2017
by Lara O'Brien and Karin Marley, interviewing I. Glenn Cohen (Faculty Director)

From the article: Women producing sperm. Or, for that matter, men producing eggs. Those could, in theory, be some of the results of a new reproductive technology that's looming on the horizon,… Read More

Medical Tourism, Medical Migration, and Global Justice: Implications for Biosecurity in a Globalized

Medical Law Review, April 11, 2017
by I. Glenn Cohen (Faculty Director)

From the paper: We live in the age of globalization. In medicine, that globalization has brought many benefits such as the diffusion of technology and the spread of health care training, but it has also… Read More

Call for Papers
Beazley Institute for Health Law and Policy at Loyola University Chicago School of Law

Deadline: June 16, 2017

General Description The Beazley Institute for Health Law and Policy at Loyola University Chicago School of Law and Annals of Health Law invite original research paper submissions for presentation… Read More

Babies From Skin Cells? Prospect Is Unsettling to Some Experts

New York Times, May 16, 2017
by Tamar Lewin, citing I. Glenn Cohen (Faculty Director)

From the article: Three prominent academics in medicine and law sounded an alarm about the possible consequences in a paper published this year. “I.V.G. may raise the specter of ‘embryo farming’… Read More

Sessions Suspends DOJ Forensic Science Commission (Audio)

Bloomberg Radio, April 11, 2017
by David Sucherman, featuring Christopher Robertson (Academic Fellow Alumnus)

Christopher Robertson, professor of Law at the University of Arizona, and Brandon Garrett, professor at the University of Virginia School of Law, discuss U.S. attorney general Jeff Sessions’ announcement… Read More

There’s a federal law to lower drug prices—and Louisiana may just use it

Ars Technica, May 4, 2017
by Beth Mole, quoting Rachel E. Sachs (Academic Fellow Alumna)

From the article: Rachel Sachs, a law professor at Washington University in St Louis, told the KHN that this makes a good argument for summoning 28 U.S.C. § 1498. “The case is strong,”… Read More

Louisiana proposes tapping a century-old patent law to cut hepatitis C drug prices

Kaiser Health News, May 2, 2017
by Sarah Jane Tribble, quoting Rachel E. Sachs (Academic Fellow Alumna)

From the article: Rachel Sachs, an associate professor of law at Washington University in St. Louis who attended the recent Johns Hopkins meeting, said she believes “the case is strong” in… Read More

Promoting demand-side innovation: prizes for payers

Journal of Law and the Biosciences, May 5, 2017
by Rachel E. Sachs (Academic Fellow Alumna)

From the paper: Promoting Healthcare Innovation on the Demand Side,1 the recent article by Professors Rebecca Eisenberg and Nicholson Price, is a thoughtful, detailed look at an issue that has gone… Read More

Yale Clinical Fellowship in Global Health Justice
Yale Law School and Yale School of Public Health

Deadline: Strongly encouraged to submit by May 5, 2017

The Yale Clinical Fellowship in Global Health Justice is a one-year position designed for law and public health graduates as well as other professionals with experience in domestic and/or international… Read More

Call for Proposals
Health Data for Action

Deadline: May 24, 2017 3 PM ET

Purpose The HD4A program will fund innovative research that uses the available data to answer important research questions. Applicants under this Call for Proposals (CFP) will write a proposal for a research… Read More

Call for Abstracts: Wiet Life Science Law Scholars Conference
Loyola University Chicago's Beazley Institute for Health Law and Policy

Deadline: June 15, 2017

Loyola University Chicago’s nationally acclaimed Beazley Institute for Health Law and Policy is pleased to invite original research submissions for its inaugural Wiet Life Science Law Scholars Conference… Read More

Petrie-Flom Welcomes New Executive Director!

Petrie-Flom Center, May 10, 2017

We are thrilled to announce that Carmel Shachar, JD, MPH (HLS ’10, HSPH ’10), will join the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School as our… Read More

Revised ‘Common Rule’ Shapes Protections For Research Participants

Health Affairs, May 2017, Vol. 36, No. 5
by By Barbara E. Bierer, Mark Barnes, and Holly Fernandez Lynch (Executive Director)

From the article: Research with human participants funded by most federal agencies is governed by a set of rules and procedures designed to protect study participants while enabling the advancement of… Read More

Value-Based Pricing For Pharmaceuticals In The Trump Administration

Health Affairs Blog, April 27, 2017
by Rachel E. Sachs (Academic Fellow Alumna), Nicholas Bagley, and Darius Lakdawalla

From the article: Everyone seems to agree: Drug prices are too damn high. Scandalous prices for new drugs and enormous price hikes on old drugs have focused public ire on the pharmaceutical… Read More

Should We Study Human Embryos Beyond 14 Days?

NOVA Next, April 26, 2017
by Jenny Morber, quoting I. Glenn Cohen (Faculty Director)

From the article: [...] Some critics view calls to re-evaluate the 14-day rule as a pernicious moving of the goalposts. How meaningful can they be, the line of reasoning goes, if scientists want to change… Read More

The new Oprah movie about Henrietta Lacks reopens a big scientific debate

Vox, April 24, 2017
by Julia Belluz, quoting Holly Fernandez Lynch (Executive Director)

From the article: [...] Holly Fernandez Lynch, executive director of the Petrie-Flom Center for Health Law Policy, Biotechnology and Bioethics at Harvard Law School, emphasized that the benefits to… Read More

Junior Research Scholar
Sports and Society Program, NYU School of Professional Studies

Deadline: May 12, 2017

JR. RESEARCH SCHOLAR: NYU School of Professional Studies, Sports and Society Program We are seeking a researcher for the NYU SPS Sports and Society Program.  It is an independent think tank based… Read More

Center Fellow
Center for Health Policy and Law, Northeastern University School of Law

Deadline: Open until filled.

This position was filled on June 26, 2017.  Responsibilities Northeastern University School of Law (NUSL) is creating a two-year fellowship, beginning as early as April 2017, with the Center for Health… Read More

Nonexceptionalism, Research Risks, and Social Media

American Journal of Bioethics, 17(5):W1-W3, 2017 (Published online April 21, 2017)
by Luke Gelinas (Research Ethics Fellow), Robin Pierce, Sabune Winkler, Glenn Cohen (Faculty Dir), Holly Fernandez Lynch (Executive Dir) & Barbara Bierer

We are grateful for the thoughtful commentaries on our target article “Using Social Media as a Research Recruitment Tool: Ethical Issues and Recommendations” (Gelinas et al. 2017),… Read More

Science Needs Your Cells

New York Times, April 21, 2017
by Holly Fernandez Lynch (Executive Director) and Steven Joffe

Biospecimens are essential to medical progress, but just medical waste to patients. Let's promote the science. From the op-ed: Many aspects of Ms. Lacks’s story reflect genuine injustice: the… Read More

Research Fellow & Lecturer in Law
Center for Health & Pharmaceutical Law & Policy at Seton Hall Law School

Deadline: Open until filled.

JOB DESCRIPTION Research Fellows at Seton Hall Law School’s Center for Health & Pharmaceutical Law & Policy are non-tenure track faculty members who conduct research and writing, develop… Read More

PFC Spotlight: Student Fellow Alumnus Matthew Baum

Petrie-Flom Center, April 13, 2017

Matthew Baum was a Student Fellow for the 2013-2014 academic year, as a second year MD-PhD student in the Health Science and Technology combined program of Harvard and MIT. Then Academic Fellow… Read More

Institutions as an Ethical Locus of Research Prioritisation

Journal of Medical Ethics, April 11, 2017 (Online)
by Luke Gelinas (Fellow in Clinical Research Ethics), Holly Fernandez Lynch (Executive Director), Barbara Bierer, I. Glenn Cohen (Faculty Director)

Introduction Ensuring that clinical trials, once launched, successfully complete and generate useful knowledge is an important and indeed ethically imperative goal, given the risks and burdens borne by… Read More

Death By 1,000 Cuts: How Republicans Can Still Alter Your Coverage

Kaiser Health News, April 10, 2017
by Jay Hancock, quoting Rachel E. Sachs (Academic Fellow Alumna)

From the article: “It’s the single-biggest problem facing the exchanges,” said Rachel Sachs, a health law professor at Washington University in St. Louis. “That would make insurers… Read More

Congress and FDA nominee heap love on ‘adaptive trials’

Science, April 7, 2017
by Kelly Servick, quoting Rachel E. Sachs (Academic Fellow Alumna)

From the article: “‘Adaptive clinical trials’ is one of those buzzwords that get brought up all the time,” says Rachel Sachs, an innovation and health law professor at Washington… Read More

Scott Gottlieb: Conflicts surround Trump’s FDA pick

CNN, April 4, 2017
by Sandee LaMotte, quoting Rachel E. Sachs (Academic Fellow Alumna)

From the article: Even some industry watchdogs are cautiously optimistic. In a New England Journal of Medicine perspective, Rachel Sachs, a Washington University associate professor of law who studies… Read More